SCHEMBL3852147

SCHEMBL3852147

Clc1cccc(N2CCN(c3ncnc4ccc(-c5ccn(C(c6ccccc6)(c6ccccc6)c6ccccc6)n5)cc34)CC2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KB1 P23443 3/20 0.48
CYP3A4 P08684 8/20 0.46
CYP1A2 P05177 7/20 0.46
LMNA P02545 7/20 0.46
ALDH1A1 P00352 7/20 0.46
CYP2C19 P33261 5/20 0.46
TSHR P16473 5/20 0.46
HIF1A Q16665 5/20 0.46
CLK4 Q9HAZ1 4/20 0.46
MAPK1 P28482 4/20 0.46
USP2 O75604 3/20 0.46
CYP2D6 P10635 3/20 0.46
HSD17B10 Q99714 2/20 0.46
MAPT P10636 4/20 0.44
ABCG2 Q9UNQ0 1/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
AKT1 P31749 1/20 0.42
HTT P42858 1/20 0.41
HPGD P15428 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3852907 0.89 CYP3A4 (0.43) CYP3A4CYP1A2LMNAALDH1A1CYP2C19
SCHEMBL3848199 0.84 CYP3A4 (0.45) CYP3A4CYP1A2LMNAALDH1A1CYP2C19
SCHEMBL3846607 0.83 CYP3A4 (0.59) CYP3A4CYP1A2LMNAALDH1A1CYP2C19
SCHEMBL3855018 0.82 PDGFRB (0.45) CYP3A4TSHRMAPTHPGDTP53
SCHEMBL3852434 0.80 ACHE (0.52) CYP3A4CYP1A2LMNAALDH1A1CYP2C19
SCHEMBL3855143 0.77 CYP3A4 (0.40) CYP3A4CYP1A2LMNAALDH1A1CYP2C19
SCHEMBL3855635 0.76 RPS6KB1 (0.59) RPS6KB1CYP3A4CYP1A2LMNAALDH1A1
SCHEMBL5852369 0.76 CYP1A2 (0.43) CYP3A4CYP1A2LMNAALDH1A1CYP2C19
Hydrochloric Acid SCHEMBL5852370 0.76 RPS6KB1 (0.58) RPS6KB1CYP3A4CYP1A2LMNAALDH1A1
SCHEMBL3845891 0.74 ACHE (0.47) CYP3A4CYP1A2LMNAALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed